Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer
- 7 August 2009
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 11 (7) , 768-774
Abstract
Objective At diagnosis, 14–27% of patients with colorectal cancer (CRC) have distant metastases (stage IV) and a poor prognosis. Today, treatment decisions for CRC patients are often made at multidisciplinary team (MDT) conferences. The aim of this study was to evaluate the effects of development and implementation of MDT assessment and treatment in patients with stage IV colon cancer (CC) and rectal cancer (RC) in a large population.Method All 1449 patients who had stage IV CRC at the time of diagnosis and were registered in the regional quality registry of Stockholm from 1995 to 2004 were included. Patients with CC and RC were grouped according to treatment and their characteristics were analysed separately.Results In total, 1000 patients with CC and 449 patients with RC had stage IV disease. Of these, 689 (68.9%) CC patients and 352 (78.4%) RC patients were assessed by a MDT and the proportion increased over the study period (P < 0.001). Surgery for metastases was undertaken on 39 (3.9%) CC patients and 38 (8.5%) RC patients (P < 0.001). CRC patients selected for metastasis surgery had 37% 5‐year survival when compared with 2% in patients who were not selected for metastasis surgery (P < 0.001).Conclusion Patients with CC were less often assessed by a MDT and less often had metastasis surgery than RC patients. The proportion of patients with CC and RC assessed by a MDT increased during the study period, as did the proportion who had surgery for metastases. MDT assessment opens up the opportunity for more aggressive treatment with better outcomes.Keywords
This publication has 24 references indexed in Scilit:
- Place of multidisciplinary consulting meetings and clinical trials in the management of colorectal cancer in France in 2000Gastroentérologie Clinique Et Biologique, 2007
- Improved survival in cancer of the colon and rectum in SwedenEuropean Journal of Surgical Oncology, 2005
- Time trends in the treatment and survival of recurrences from colorectal cancerAnnals of Oncology, 2005
- Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgeryGut, 2005
- Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET)Annals of Surgery, 2004
- Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal MetastasesAnnals of Surgery, 2002
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001
- Extension of the Frontiers of Surgical Indications in the Treatment of Liver Metastases From Colorectal CancerAnnals of Surgery, 2000
- Natural history of liver metastases from colorectal carcinomaJournal of Gastrointestinal Surgery, 1997
- Survival in patients with large-bowel cancerDiseases of the Colon & Rectum, 1990